<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head>


  <title>0078 - FHIR v4.0.1</title>

  
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <meta name="author" content="http://hl7.org/fhir"/>

  <link rel="stylesheet" href="../../fhir.css"/>
  <link rel="Prev" href="http://hl7.org/fhir/v2/0078/index.html"/>

    <!-- Bootstrap core CSS -->
  <link rel="stylesheet" href="../.././dist/css/bootstrap.css"/>
  <link rel="stylesheet" href="../.././assets/css/bootstrap-fhir.css"/>

    <!-- Project extras -->
  <link rel="stylesheet" href="../.././assets/css/project.css"/>
  <link rel="stylesheet" href="../../fhir-pub.css"/>
  <link rel="stylesheet" href="../.././assets/css/pygments-manni.css"/>
	<link rel="stylesheet" href="../../jquery-ui.css"/>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- [if lt IE 9]>
  <script src="../.././assets/js/html5shiv.js"></script>
  <script src="../.././assets/js/respond.min.js"></script>
  <![endif] -->

    <!-- Favicons -->
  <link sizes="144x144" rel="apple-touch-icon-precomposed" href="../.././assets/ico/apple-touch-icon-144-precomposed.png"/>
  <link sizes="114x114" rel="apple-touch-icon-precomposed" href="../.././assets/ico/apple-touch-icon-114-precomposed.png"/>
  <link sizes="72x72" rel="apple-touch-icon-precomposed" href="../.././assets/ico/apple-touch-icon-72-precomposed.png"/>
  <link rel="apple-touch-icon-precomposed" href="../.././assets/ico/apple-touch-icon-57-precomposed.png"/>
  <link rel="shortcut icon" href="../.././assets/ico/favicon.png"/>

</head>
<body>
	<div id="segment-header" class="segment">  <!-- segment-header -->	
		<div class="container">  <!-- container -->
			<a no-external="true" id="logo" href="http://hl7.org/fhir"><img src="../.././assets/images/fhir-logo-www.png" alt="logo fhir" width="249" height="60"/> </a>
			<div id="hl7-status">
				<b>Release 4</b>
			</div>       	
			
			<div id="hl7-nav">
				 <a no-external="true" id="hl7-logo" href="http://www.hl7.org">
					<img src="../.././assets/images/hl7-logo.png" width="42" alt="visit the hl7 website" height="50"/>
				</a> 
			</div>       	
			<div id="hl7-nav"><a no-external="true" id="hl7-logo" href="http://hl7.org/fhir/search.cfm"><img src="./../../assets/images/search.png" alt="Search FHIR"/></a></div> 
      <div style="text-align: right; float: right;" id="hl7-status">				
        <a onclick="window.open('https://hl7.org/fhir/R4'+window.location.pathname, '_blank');return false;" href="#">Открыть эту страницу в оригинале FHIR 4.0.1</a>        
			</div>   
		</div>
		<div class="container">  <!-- container -->
	</div></div>  <!-- /segment-header -->	


	<div id="segment-navbar" class="segment">  <!-- segment-navbar -->
		<div id="stripe"> </div>
		<div class="container">  <!-- container -->
   <!-- HEADER CONTENT -->
 	      		 	      		      		
			<nav class="navbar navbar-inverse">
				<div class="container">
					<button data-target=".navbar-inverse-collapse" data-toggle="collapse" type="button" class="navbar-toggle">
						<span class="icon-bar"> </span>
						<span class="icon-bar"> </span>
						<span class="icon-bar"> </span>
					</button>
					<a href="../../index.html" class="navbar-brand hidden">FHIR</a>
					<div class="nav-collapse collapse navbar-inverse-collapse">
						<ul class="nav navbar-nav">
              <li><a href="../.././index.html">Home</a></li>
              <li><a href="../.././modules.html">Getting Started</a></li>
              <li><a href="../.././documentation.html">Documentation</a></li>
              <li><a href="../.././resourcelist.html">Resources</a></li>
              <li><a href="../.././profilelist.html">Profiles</a></li>
              <li><a href="../.././extensibility-registry.html">Extensions</a></li>
              <li><a href="../.././operationslist.html">Operations</a></li>
              <li><a href="../.././terminologies-systems.html">Terminologies</a></li>
						</ul>
					</div>  <!-- /.nav-collapse -->
				</div>  <!-- /.container -->
			</nav>  <!-- /.navbar -->
      		
  <!-- /HEADER CONTENT -->				
		</div>  <!-- /container -->
	</div>  <!-- /segment-navbar -->
	

	<div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
		<div class="container">  <!-- container -->	
			<ul class="breadcrumb">
        <li><a href="../../terminology-module.html"><img src="../../terminology.png"/> Terminology</a></li>        <li><a href="../../terminologies-systems.html">Code Systems</a></li>        <li><b>V2 Table</b></li>          <!-- 0078.html / v2Vocab / V2 Table -->

			</ul>	
		</div>  <!-- /container -->
	</div>  <!-- /segment-breadcrumb -->
	

	<div id="segment-content" class="segment">  <!-- segment-content -->
	<div class="container">  <!-- container -->
            <div class="row">
            	<div class="inner-wrapper">
  <!-- CONTENT CONTENT -->


<div class="col-12">  <!-- ReleaseHeader --><p id="publish-box"></p>  <!-- EndReleaseHeader -->

<ul class="nav nav-tabs"><li><a href="../../terminologies.html">Using Codes</a></li><li><a href="../../terminologies-systems.html">Code Systems</a></li><li><a href="../../terminologies-valuesets.html">Value Sets</a></li><li><a href="../../terminologies-conceptmaps.html">Concept Maps</a></li><li><a href="../../identifier-registry.html">Identifier Systems</a></li></ul>


<a name="table"></a>
<h1 class="self-link-parent"><span class="sectioncount">4.3.15.78<a name="4.3.15.78"> </a></span> HL7 Version 2 Table 0078 <a href="index.html#4.3.15.78" title="link to here" class="self-link"><svg viewBox="0 0 1792 1792" width="20" class="self-link" height="20"><path d="M1520 1216q0-40-28-68l-208-208q-28-28-68-28-42 0-72 32 3 3 19 18.5t21.5 21.5 15 19 13 25.5 3.5 27.5q0 40-28 68t-68 28q-15 0-27.5-3.5t-25.5-13-19-15-21.5-21.5-18.5-19q-33 31-33 73 0 40 28 68l206 207q27 27 68 27 40 0 68-26l147-146q28-28 28-67zm-703-705q0-40-28-68l-206-207q-28-28-68-28-39 0-68 27l-147 146q-28 28-28 67 0 40 28 68l208 208q27 27 68 27 42 0 72-31-3-3-19-18.5t-21.5-21.5-15-19-13-25.5-3.5-27.5q0-40 28-68t68-28q15 0 27.5 3.5t25.5 13 19 15 21.5 21.5 18.5 19q33-31 33-73zm895 705q0 120-85 203l-147 146q-83 83-203 83-121 0-204-85l-206-207q-83-83-83-203 0-123 88-209l-88-88q-86 88-208 88-120 0-204-84l-208-208q-84-84-84-204t85-203l147-146q83-83 203-83 121 0 204 85l206 207q83 83 83 203 0 123-88 209l88 88q86-88 208-88 120 0 204 84l208 208q84 84 84 204z" fill="navy"></path></svg></a></h1>
<table class="colse">
 <tr><td><a href="http://www.hl7.org/Special/committees/Vocab/index.cfm">Vocabulary <img src="../../external.png" style="text-align: baseline"/></a> Work Group</td><td>&nbsp;<a href="../../versions.html#maturity" title="Maturity Level">Maturity Level</a>: N/A</td><td><a href="../../versions.html#std-process">External</a></td>  <!-- !ns! --><td><a href="../../metadatatypes.html#UsageContext">Use Context</a>: Any</td></tr>
</table>
<p>
This is a table defined as part of <a href="http://www.hl7.org/implement/standards/product_brief.cfm?product_id=185">HL7 v2 <img src="../../external.png" style="text-align: baseline"/></a>. 
</p>
<p><b>Summary</b></p>
<table class="grid">
 <tr><td>Code System URL:</td><td><code>http://terminology.hl7.org/CodeSystem/v2-0078</code></td></tr>
 <tr><td>Value Set URL:</td><td><code>http://terminology.hl7.org/ValueSet/v2-0078</code></td></tr>
 <tr><td>Version:</td><td>2.9</td></tr>
 <tr><td>Name:</td><td>v2.0078</td></tr>
 <tr><td>Title:</td><td>v2 ABNORMAL FLAGS</td></tr>
 <tr><td>Definition:</td><td><p>HL7-defined code system of concepts which specify a categorical assessment of an observation value.</p>
<p>Notes:</p>
<p>This is being communicated in v2.x in OBX-8 (Observation Interpretation), in v3 in ObservationInterpretation (CWE) in R1 (Representative Realm) and in FHIR in    Observation.interpretation.</p>
</td></tr>
 <tr><td>OID:</td><td>??</td></tr>

 <tr><td>CodeSystem Resource</td><td><a href="v2-0078.cs.xml.html">XML</a> / <a href="v2-0078.cs.json.html">JSON</a></td></tr>
 <tr><td>ValueSet Resource</td><td><a href="v2-0078.vs.xml.html">XML</a> / <a href="v2-0078.vs.json.html">JSON</a></td></tr>
</table>

  <p>
  Note: V2 code systems may or may not be case sensitive. V2 Code systems will have the <code>CodeSystem.caseSensitive</code> correctly populated in a future version of this specification.
  </p>




<p>
This value set is not currently used
</p>


<a name="definition"></a>
<h2 class="self-link-parent"><span class="sectioncount">4.3.15.78.1</span> Code System Content <a href="index.html#definition" title="link to here" class="self-link"><svg viewBox="0 0 1792 1792" width="20" class="self-link" height="20"><path d="M1520 1216q0-40-28-68l-208-208q-28-28-68-28-42 0-72 32 3 3 19 18.5t21.5 21.5 15 19 13 25.5 3.5 27.5q0 40-28 68t-68 28q-15 0-27.5-3.5t-25.5-13-19-15-21.5-21.5-18.5-19q-33 31-33 73 0 40 28 68l206 207q27 27 68 27 40 0 68-26l147-146q28-28 28-67zm-703-705q0-40-28-68l-206-207q-28-28-68-28-39 0-68 27l-147 146q-28 28-28 67 0 40 28 68l208 208q27 27 68 27 42 0 72-31-3-3-19-18.5t-21.5-21.5-15-19-13-25.5-3.5-27.5q0-40 28-68t68-28q15 0 27.5 3.5t25.5 13 19 15 21.5 21.5 18.5 19q33-31 33-73zm895 705q0 120-85 203l-147 146q-83 83-203 83-121 0-204-85l-206-207q-83-83-83-203 0-123 88-209l-88-88q-86 88-208 88-120 0-204-84l-208-208q-84-84-84-204t85-203l147-146q83-83 203-83 121 0 204 85l206 207q83 83 83 203 0 123-88 209l88 88q86-88 208-88 120 0 204 84l208 208q84 84 84 204z" fill="navy"></path></svg></a></h2>

<div style="border-right-style: none;" id="tabs">
<ul>
<li><a href="#tabs-all">All Languages</a></li>
<li><a href="#tabs-en">English</a></li>
<li><a href="#tabs-de">Deutsch (German)</a></li>
<li><a href="#tabs-nl">Nederlands (Dutch)</a></li>
</ul>
<div id="tabs-all">
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Properties</b></p><table class="grid"><tr><td><b>Code</b></td><td><b>URL</b></td><td><b>Description</b></td><td><b>Type</b></td></tr><tr><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>A property that indicates the status of the concept. One of active, experimental, deprecated, retired</td><td>code</td></tr><tr><td>deprecationDate</td><td>http://hl7.org/fhir/concept-properties#deprecationDate</td><td>The date at which a concept was deprecated. Concepts that are deprecated but not inactive can still be used, but their use is discouraged</td><td>dateTime</td></tr></table><p>This code system http://terminology.hl7.org/CodeSystem/v2-0078 defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>Deprecated</b></td><td><b>Comments</b></td><td><b>Version</b></td></tr><tr><td style="white-space:nowrap">&lt;<a name="v2-0078-.60"> </a></td><td>en: Off scale low<br/>de: Unter Meßbereich (Extremwertverletzung)<br/>nl: Onder absolute ondergrens instrumentschaal</td><td></td><td>Deprecated</td><td>en: The result is below the minimum detection limit (the test procedure or equipment is the limiting factor).
Synonyms: Below analytical limit, low off scale<br/>nl: Het resultaat is onder de minimum detecteerbare grens (de testprocedure of apparaat is de beperkende factor). Synoniemen: Onder analytische grens, off-scale low</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">&gt;<a name="v2-0078-.62"> </a></td><td>en: Off scale high<br/>de: Über Meßbereich (Extremwertverletzung)<br/>nl: Boven absolute bovengrens instrumentschaal</td><td></td><td>Deprecated</td><td>en: The result is above the maximum quantifiable limit (the test procedure or equipment is the limiting factor).
Synonyms: Above analytical limit, high off scale<br/>nl: Het resultaat is boven de maximum detecteerbare grens (de testprocedure of apparaat is de beperkende factor). Synoniemen: Boven analytische grens, off-scale high</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">A<a name="v2-0078-A"> </a></td><td>en: Abnormal<br/>de: anormal<br/>nl: Abnormaal</td><td></td><td>Deprecated</td><td>en: The result or observation value is outside the reference range or expected norm (as defined for the respective test procedure).
Note: Typically applies to non-numeric results.<br/>nl: Het resultaat of observatiewaarde is buiten de referentiewaarden of afwijkend van de verwachte norm (zoals gedefinieerd voor de betreffende testprocedure. NB: Meest van toepassing op niet-numerieke resultaten.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">AA<a name="v2-0078-AA"> </a></td><td>en: Critically abnormal<br/>de: Pathologisch (nicht numerisch)<br/>nl: Kritiek abnormaal</td><td></td><td>Deprecated</td><td>en: The result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure).
[Note: Typically applies to non-numeric results.  Analogous to critical/panic limits for numeric results.]<br/>nl: Het resultaat of observatiewaarde is buiten de referentiewaarden of afwijkend van de verwachte norm waarvoor onmiddellijke actie ondernomen zou moeten worden uit het oogpunt van patiëntveiligheid (zoals gedefinieerd voor de betreffende testprocedure. NB: Meest van toepassing op niet-numerieke resultaten.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">AC<a name="v2-0078-AC"> </a></td><td>en: Anti-complementary substances present<br/>nl: Anti-complementaire stoffen aanwezig</td><td></td><td>Deprecated</td><td>en: Deprecated<br/>nl: Vervallen</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">B<a name="v2-0078-B"> </a></td><td>en: Better<br/>de: besser<br/>nl: Beter</td><td></td><td>Deprecated</td><td>en: The current result or observation value has improved compared to the previous result or observation value (the change is significant as defined in the respective test procedure).
Note: This can be applied to quantitative or qualitative observations.<br/>nl: Het huidige resultaat of observatiewaarde is verbeterd ten opzichte van vorige resultaat of observatiewaarde (de wijziging is significant zoals gedefinieerd in de betreffende testprocedure). NB: van toepassing op kwantitatieve of kwalitatieve observaties</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">D<a name="v2-0078-D"> </a></td><td>en: Significant change down<br/>de: Deutlicher Trend nach unten<br/>nl: Significante wijzging omlaag</td><td></td><td>Deprecated</td><td>en: The current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure).<br/>nl: Het huidige resultaat is verlaagd ten opzichte van het vorige resultaat voor een kwantitatieve observatie (de wijziging is significant zoals gedefinieerd voor de betreffende testprocedure).</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">DET<a name="v2-0078-DET"> </a></td><td>en: Detected<br/>nl: Gedetecteerd</td><td></td><td>Deprecated</td><td>en: The measurement of the specified component / analyte, organism or clinical sign above the limit of detection of the performed test or procedure.<br/>nl: De meting van het gespecificeerde component / analyte, organisme of klinische teken boven de grenswaarde voor detectie van de uitgevoerde test of procedure.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">H<a name="v2-0078-H"> </a></td><td>en: High<br/>de: Oberhalb oberer Grenze Referenzbereich<br/>nl: Hoog</td><td></td><td>Deprecated</td><td>en: The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure).
Synonym: Above high normal<br/>nl: Het resultaat voor een kwalitatieve observatie is boven de bovengrens van de referentiewaarden (zoals gedefinieerd voor de betreffende testprocedure). Synoniem: Boven bovenste normaalgrens</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HH<a name="v2-0078-HH"> </a></td><td>en: Critically high<br/>de: Oberhalb oberer pathologischer Grenze<br/>nl: Kritiek hoog</td><td></td><td>Deprecated</td><td>en: The result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure).
Synonym: Above upper panic limits<br/>nl: De resultaten voor een kwantitatieve observatie is boven een referentieniveau waarop onmiddellijke actie overwogen moet worden uit het oogpunt van patiëntveiligheid (zoals gedefinieerd voor betreffende testprocedure. Synoniem: Boven hoogste kritieke grens</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HM<a name="v2-0078-HM"> </a></td><td>en: Hold for Medical Review<br/>nl: Vastgehouden voor medische review</td><td></td><td>Deprecated</td><td>en: Deprecated<br/>nl: Vervallen</td><td>added v2.8, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HU<a name="v2-0078-HU"> </a></td><td>en: Very high<br/>nl: Zeer hoog</td><td></td><td>Deprecated</td><td>en: Significantly high: A test result that is significantly higher than the reference (normal) or therapeutic interval, but has not reached the critically high value and might need special attention, as defined by the laboratory or the clinician.

Note: This level is situated between ‘H’ and ‘HH’.<br/>nl: Significant hoog: Een testresultaat die significant hoger is dan de referentie (normaal) of therapeutisch interval, maar nog niet op de kritiek hoger waarde zit en mogelijke speciale aandacht nodig heeft, zoals gedefinieerd door het laboratorium of de arts. NB: T</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">I<a name="v2-0078-I"> </a></td><td>en: Intermediate<br/>de: Intermediär<br/>nl: Gemiddeld</td><td></td><td>Deprecated</td><td>en: Bacterial strain inhibited in vitro by a
concentration of an antimicrobial agent that is associated with
uncertain therapeutic effect.
Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm)
Projects: ISO 20776-1, ISO 20776-2

Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.

Note 2: This class of susceptibility implies that an infection due to the
isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.

Note 3: This class also indicates a “buffer zone,” to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.

Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).<br/>nl: Bacteriële stam geblokkeerd door in vitro concentratie van een anti-bacteriële agens die is gekoppeld aan een onzekere kans op therapeutisch effect. Referentie: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Ter</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">IE<a name="v2-0078-IE"> </a></td><td>en: Insufficient evidence<br/>nl: Onvoldoende bewijs</td><td></td><td>Deprecated</td><td>en: There is insufficient evidence that the species in question is a good target for therapy with the drug.  A categorical interpretation is not possible.
Reference: EUCAST

Note: A MIC with “IE” and/or a comment may be reported (without an accompanying S, I or R-categorization).<br/>nl: Er is onvoldoende bewijs dat de betreffende soort een goed doel is voor therapie met de medicatie. Een categorische interpretatie is niet mogelijk. Referentie: EUCA. NB: Een MIC met "IE" en/of een opmerking wordt mogelijk gerapporteerd (zonder bijbehorende S,</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">IND<a name="v2-0078-IND"> </a></td><td>en: Indeterminate<br/>nl: Onbepaald</td><td></td><td>Deprecated</td><td>en: The specified component / analyte, organism or clinical sign could neither be declared positive / negative or detected / not detected by the performed test or procedure.<br/>nl: Het gespecificeerde component / analyte, organisme of klinische teken kon niet positief / negatief of gedetecteerd / niet-gedetecteerd door de uitgevoerde test of procedure</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">L<a name="v2-0078-L"> </a></td><td>en: Low<br/>de: Unterhalb unterer Grenze Referenzbereich<br/>nl: Laag</td><td></td><td>Deprecated</td><td>en: The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure).
Synonym: Below low normal<br/>nl: Het resultaat voor een kwalitatieve observatie is onder de ondergrens van de referentiewaarden (zoals gedefinieerd voor de betreffende testprocedure). Synoniem: Onder onderste normaalgrens</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">LL<a name="v2-0078-LL"> </a></td><td>en: Critically low<br/>de: Unterhalb unterer pathologischer Grenze<br/>nl: Kritiek laag</td><td></td><td>Deprecated</td><td>en: The result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure).
Synonym: Below lower panic limits<br/>nl: De resultaten voor een kwantitatieve observatie is onder een referentieniveau waarop onmiddellijke actie overwogen moet worden uit het oogpunt van patiëntveiligheid (zoals gedefinieerd voor betreffende testprocedure. Synoniem: Onder laagste kritieke grens</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">LU<a name="v2-0078-LU"> </a></td><td>en: Very low<br/>nl: Zeer laag</td><td></td><td>Deprecated</td><td>en: Significantly low: A test result that is significantly lower than the reference (normal) or therapeutic interval, but has not reached the critically low value and might need special attention, as defined by the laboratory or the clinician.

Note: This level is situated between ‘L’ and ‘LL’.<br/>nl: Significant laag: Een testresultaat die significant lager is dan de referentie (normaal) of therapeutisch interval, maar nog niet op de kritiek lage waarde zit en mogelijke speciale aandacht nodig heeft, zoals gedefinieerd door het laboratorium of de arts. NB: T</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">MS<a name="v2-0078-MS"> </a></td><td>en: Moderately susceptible. Indicates for microbiology susceptibilities only.<br/>de: mäßig empfindlich<br/>nl: Gemiddeld gevoelig. Alleen voor microbiologische gevoeligheid.</td><td></td><td>Deprecated</td><td>en: Deprecated - CLSI now only supports S, I &amp; R. This information can be found in CLSI document M100-S22;  Vol. 32 No.3;  CLSI Performance
Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement.  Jan 2012.<br/>nl: Vervallen - CLSI ondersteunt nu alleen nog S, I &amp; R. Deze informatie vindt u in CLSI document M100-S22;  Vol. 32 No.3;  CLSI Performance
Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement.  Jan 2012.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">N<a name="v2-0078-N"> </a></td><td>en: Normal<br/>de: Normal (nicht numerisch)<br/>nl: Normaal</td><td></td><td>Deprecated</td><td>en: The result or observation value is within the reference range or expected norm (as defined for the respective test procedure).
Note: Applies to numeric or non-numeric results.<br/>nl: Het resultaat of observatiewaarde is binnen de referentiewaarden of verwachte norm (zoals gedefinieerd voor de betreffende testprocedure. NB: Van toepassing op numerieke of niet-numerieke resultaten.</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">ND<a name="v2-0078-ND"> </a></td><td>en: Not Detected<br/>nl: Niet-gedetecteerd</td><td></td><td>Deprecated</td><td>en: The presence of the specified component / analyte, organism or clinical sign could not be determined  within the limit of detection of the performed test or procedure.<br/>nl: De meting van het gespecificeerde component / analyte, organisme of klinische teken kon niet worden gedetecteerd binnen de grenswaarde voor detectie van de uitgevoerde test of procedure.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NEG<a name="v2-0078-NEG"> </a></td><td>en: Negative<br/>nl: Negatief</td><td></td><td>Deprecated</td><td>en: An absence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure.
Note: Negative does not necessarily imply the complete absence of the specified item.<br/>nl: Een afwezigheidsbevinding voor het gespecificeerde component / analyte, organisme of klinische teken gebaseerd op de geldende grenswaarde van de uitgevoerde test of procedure.
NB: Negatief betekent niet noodzakelijk de volledige afwezigheid van het het gespecificeerde item.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NR<a name="v2-0078-NR"> </a></td><td>en: Non-reactive<br/>nl: Niet-reactief</td><td></td><td>Deprecated</td><td>en: An absence finding used to indicate that the specified component / analyte did not react measurably with the reagent.<br/>nl: Een afwezigheidsbevinding om aan te geven dat het gespecificeerde component / analyte niet meetbaar reageerde met het reagens.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NS<a name="v2-0078-NS"> </a></td><td>en: Non-susceptible<br/>nl: Niet-gevoelig</td><td></td><td>Deprecated</td><td>en: A category used for isolates for which only a susceptible interpretive criterion has been designated because of the absence or rare occurrence of resistant strains. Isolates that have MICs above or zone diameters below the value indicated for the susceptible breakpoint should be reported as non-susceptible.

Synonym: decreased susceptibility

Note 1: An isolate that is interpreted as non-susceptible does not necessarily mean that the isolate has a resistance mechanism. It is possible that isolates with MICs above the susceptible breakpoint that lack resistance mechanisms may be encountered within the wild-type distribution subsequent to the time the susceptible-only breakpoint is set.

Note 2: For strains yielding results in the “nonsusceptible” category, organism identification and antimicrobial susceptibility test results should be confirmed.<br/>nl: Een categorie voor isolaten waarvoor alleen een gevoelig interpretabel criterium is ontworpen vanwege de afwezigheid of zeldzaam voorkomen van resistente stammen. Isolaten met MIC's boven of zonediameters onder de waarde aangewezen voor de gevoeli</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">null<a name="v2-0078-null"> </a></td><td>en: No range defined, or normal ranges don't apply<br/>de: Kein Referenzbereich / Referenzbereich nicht anwendbar<br/>nl: Geen referentiewaarden gedefinieerd of normale waarden niet van toepassing</td><td></td><td>Deprecated</td><td>en: Deprecated<br/>nl: Vervallen</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">OBX<a name="v2-0078-OBX"> </a></td><td>en: Interpretation qualifiers in separate OBX segments<br/>nl: Interpretatie qualifiers in afzonderlijke OBX-segmenten</td><td></td><td>Deprecated</td><td>en: Deprecated<br/>nl: Vervallen</td><td>added v2.8, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">POS<a name="v2-0078-POS"> </a></td><td>en: Positive<br/>nl: Positief</td><td></td><td>Deprecated</td><td>en: A presence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure.<br/>nl: Een aanwezigheidsbevinding voor het gespecificeerde component / analyte, organisme of klinische teken gebaseerd op de geldende grenswaarde van de uitgevoerde test of procedure.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">QCF<a name="v2-0078-QCF"> </a></td><td>en: Quality Control Failure<br/>nl: Kwaliteitscontrole fout</td><td></td><td>Deprecated</td><td>en: Deprecated<br/>nl: Vervallen</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">R<a name="v2-0078-R"> </a></td><td>en: Resistant<br/>de: Resistent<br/>nl: Resistent</td><td></td><td>Deprecated</td><td>en: Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure.
Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm)
Projects: ISO 20776-1, ISO 20776-2

Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.

Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).<br/>nl: Bacteriële stam geblokkeerd door in vitro concentratie van een anti-bacteriële agens die is gekoppeld aan een hoge kans op therapeutisch falen. Referentie: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmoniz</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">RR<a name="v2-0078-RR"> </a></td><td>en: Reactive<br/>nl: Reactief</td><td></td><td>Deprecated</td><td>en: A presence finding used to indicate that the specified component / analyte reacted with the reagent above the reliably measurable limit of the performed test.<br/>nl: Een aanwezigheidsbevinding om aan te geven dat het gespecificeerde component / analyte reageerde met het reagens, boven de betrouwbaar meetbare grens van de uitgevoerde test.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">S<a name="v2-0078-S"> </a></td><td>en: Susceptible<br/>de: Empfindlich<br/>nl: Gevoelig</td><td></td><td>Deprecated</td><td>en: Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success.
Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) 
Projects: ISO 20776-1, ISO 20776-2

Synonym (earlier term): Sensitive

Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.

Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).<br/>nl: Bacteriële stam geblokkeerd door in vitro concentratie van een anti-bacteriële agens die is gekoppeld aan een hoge kans op therapeutisch succes. Referentie: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmoniz</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SDD<a name="v2-0078-SDD"> </a></td><td>en: Susceptible-dose dependent<br/>nl: Gevoelig dosis-afhankelijk</td><td></td><td>Deprecated</td><td>en: A category that includes isolates with antimicrobial agent minimum inhibitory concentrations (MICs) that approach usually attainable blood and tissue levels and for which response rates may be lower than for susceptible isolates.
Reference: CLSI document M44-A2 2009 “Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline – second edition” – page 2.<br/>nl: Een categorie inclusief isolaten met anti-microben agens minimum blokkerende concentraties (MIC's) die in de buurt van normaal bereikbare bloed en weefsel-niveau's komen en waarvoor antwoordratio's mogelijk lager zijn dan voor gevoelige isolaten. Referentie: CLSI document</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SYN-R<a name="v2-0078-SYN-R"> </a></td><td>en: Synergy - resistant<br/>nl: Synergie - resistent</td><td></td><td>Deprecated</td><td>en: A category for isolates where the bacteria (e.g. enterococci) are not susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will not be effective. 

Usage Note: Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside.

Open Issue: The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found.<br/>nl: Een categorie voor isolaten waarbij de bacteriën (bijv. enterococcen) in vitro niet gevoelig zijn voor een combinatietherapie (bijv. een hoog-niveau aminoglycoside en celwand actieve agens). Dit is een goede indicatie dat combinatietherapie niet effectief zal zijn. Gebr</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SYN-S<a name="v2-0078-SYN-S"> </a></td><td>en: Synergy - susceptible<br/>nl: Synergie - gevoelig</td><td></td><td>Deprecated</td><td>en: A category for isolates where the bacteria (e.g. enterococci) are susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will be effective. 

Usage Note: Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside.

Open Issue: The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found.<br/>nl: Een categorie voor isolaten waarbij de bacteriën (bijv. enterococcen) in vitro gevoelig zijn voor een combinatietherapie (bijv. een hoog-niveau aminoglycoside en celwand actieve agens). Dit is een goede indicatie dat combinatietherapie effectief zal zijn. Gebr</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">TOX<a name="v2-0078-TOX"> </a></td><td>en: Cytotoxic substance present<br/>nl: Cytotoxische stoffen aanwezig</td><td></td><td>Deprecated</td><td>en: Deprecated<br/>nl: Vervallen</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">U<a name="v2-0078-U"> </a></td><td>en: Significant change up<br/>de: Deutlicher Trend nach oben<br/>nl: Significante wijzging omhoog</td><td></td><td>Deprecated</td><td>en: The current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure).<br/>nl: Het huidige resultaat is verhoogd ten opzichte van het vorige resultaat voor een kwantitatieve observatie (de wijziging is significant zoals gedefinieerd voor de betreffende testprocedure).</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">VS<a name="v2-0078-VS"> </a></td><td>en: Very susceptible. Indicates for microbiology susceptibilities only.<br/>de: Sehr empfindlich<br/>nl: Zeer gevoelig. Alleen voor microbiologische gevoeligheid.</td><td></td><td>Deprecated</td><td>en: Deprecated - CLSI now only supports S, I &amp; R. This information can be found in CLSI document M100-S22;  Vol. 32 No.3;  CLSI Performance
Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement.  Jan 2012.<br/>nl: Vervallen - CLSI ondersteunt nu alleen nog S, I &amp; R. Deze informatie vindt u in CLSI document M100-S22;  Vol. 32 No.3;  CLSI Performance
Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement.  Jan 2012.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">W<a name="v2-0078-W"> </a></td><td>en: Worse<br/>de: Verschlechterung<br/>nl: Slechter</td><td></td><td>Deprecated</td><td>en: The current result or observation value has degraded compared to the previous result or observation value (the change is significant as defined in the respective test procedure).
Note: This can be applied to quantitative or qualitative observations.<br/>nl: Het huidige resultaat of observatiewaarde is verslechterd ten opzichte van vorige resultaat of observatiewaarde (de wijziging is significant zoals gedefinieerd in de betreffende testprocedure). NB: van toepassing op kwantitatieve of kwalitatieve observaties</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">WR<a name="v2-0078-WR"> </a></td><td>en: Weakly reactive<br/>nl: Zwak reactief</td><td></td><td>Deprecated</td><td>en: A weighted presence finding used to indicate that the specified component / analyte reacted with the reagent, but below the reliably measurable limit of the performed test.<br/>nl: Een gewogen aanwezigheidsbevinding om aan te geven dat het gespecificeerde component / analyte reageerde met het reagens, maar onder de betrouwbaar meetbare grens van de uitgevoerde test.</td><td>added v2.7, removed after v2.8.2</td></tr></table></div></div>
<div id="tabs-en">
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Properties</b></p><table class="grid"><tr><td><b>Code</b></td><td><b>URL</b></td><td><b>Description</b></td><td><b>Type</b></td></tr><tr><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>A property that indicates the status of the concept. One of active, experimental, deprecated, retired</td><td>code</td></tr><tr><td>deprecationDate</td><td>http://hl7.org/fhir/concept-properties#deprecationDate</td><td>The date at which a concept was deprecated. Concepts that are deprecated but not inactive can still be used, but their use is discouraged</td><td>dateTime</td></tr></table><p>This code system http://terminology.hl7.org/CodeSystem/v2-0078 defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>Deprecated</b></td><td><b>Comments</b></td><td><b>Version</b></td></tr><tr><td style="white-space:nowrap">&lt;<a name="v2-0078-.60"> </a></td><td>Off scale low</td><td></td><td>Deprecated</td><td>The result is below the minimum detection limit (the test procedure or equipment is the limiting factor).
Synonyms: Below analytical limit, low off scale</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">&gt;<a name="v2-0078-.62"> </a></td><td>Off scale high</td><td></td><td>Deprecated</td><td>The result is above the maximum quantifiable limit (the test procedure or equipment is the limiting factor).
Synonyms: Above analytical limit, high off scale</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">A<a name="v2-0078-A"> </a></td><td>Abnormal</td><td></td><td>Deprecated</td><td>The result or observation value is outside the reference range or expected norm (as defined for the respective test procedure).
Note: Typically applies to non-numeric results.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">AA<a name="v2-0078-AA"> </a></td><td>Critically abnormal</td><td></td><td>Deprecated</td><td>The result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure).
[Note: Typically applies to non-numeric results.  Analogous to critical/panic limits for numeric results.]</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">AC<a name="v2-0078-AC"> </a></td><td>Anti-complementary substances present</td><td></td><td>Deprecated</td><td>Deprecated</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">B<a name="v2-0078-B"> </a></td><td>Better</td><td></td><td>Deprecated</td><td>The current result or observation value has improved compared to the previous result or observation value (the change is significant as defined in the respective test procedure).
Note: This can be applied to quantitative or qualitative observations.</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">D<a name="v2-0078-D"> </a></td><td>Significant change down</td><td></td><td>Deprecated</td><td>The current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure).</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">DET<a name="v2-0078-DET"> </a></td><td>Detected</td><td></td><td>Deprecated</td><td>The measurement of the specified component / analyte, organism or clinical sign above the limit of detection of the performed test or procedure.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">H<a name="v2-0078-H"> </a></td><td>High</td><td></td><td>Deprecated</td><td>The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure).
Synonym: Above high normal</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HH<a name="v2-0078-HH"> </a></td><td>Critically high</td><td></td><td>Deprecated</td><td>The result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure).
Synonym: Above upper panic limits</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HM<a name="v2-0078-HM"> </a></td><td>Hold for Medical Review</td><td></td><td>Deprecated</td><td>Deprecated</td><td>added v2.8, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HU<a name="v2-0078-HU"> </a></td><td>Very high</td><td></td><td>Deprecated</td><td>Significantly high: A test result that is significantly higher than the reference (normal) or therapeutic interval, but has not reached the critically high value and might need special attention, as defined by the laboratory or the clinician.

Note: This level is situated between ‘H’ and ‘HH’.</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">I<a name="v2-0078-I"> </a></td><td>Intermediate</td><td></td><td>Deprecated</td><td>Bacterial strain inhibited in vitro by a
concentration of an antimicrobial agent that is associated with
uncertain therapeutic effect.
Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm)
Projects: ISO 20776-1, ISO 20776-2

Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.

Note 2: This class of susceptibility implies that an infection due to the
isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.

Note 3: This class also indicates a “buffer zone,” to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.

Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">IE<a name="v2-0078-IE"> </a></td><td>Insufficient evidence</td><td></td><td>Deprecated</td><td>There is insufficient evidence that the species in question is a good target for therapy with the drug.  A categorical interpretation is not possible.
Reference: EUCAST

Note: A MIC with “IE” and/or a comment may be reported (without an accompanying S, I or R-categorization).</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">IND<a name="v2-0078-IND"> </a></td><td>Indeterminate</td><td></td><td>Deprecated</td><td>The specified component / analyte, organism or clinical sign could neither be declared positive / negative or detected / not detected by the performed test or procedure.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">L<a name="v2-0078-L"> </a></td><td>Low</td><td></td><td>Deprecated</td><td>The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure).
Synonym: Below low normal</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">LL<a name="v2-0078-LL"> </a></td><td>Critically low</td><td></td><td>Deprecated</td><td>The result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure).
Synonym: Below lower panic limits</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">LU<a name="v2-0078-LU"> </a></td><td>Very low</td><td></td><td>Deprecated</td><td>Significantly low: A test result that is significantly lower than the reference (normal) or therapeutic interval, but has not reached the critically low value and might need special attention, as defined by the laboratory or the clinician.

Note: This level is situated between ‘L’ and ‘LL’.</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">MS<a name="v2-0078-MS"> </a></td><td>Moderately susceptible. Indicates for microbiology susceptibilities only.</td><td></td><td>Deprecated</td><td>Deprecated - CLSI now only supports S, I &amp; R. This information can be found in CLSI document M100-S22;  Vol. 32 No.3;  CLSI Performance
Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement.  Jan 2012.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">N<a name="v2-0078-N"> </a></td><td>Normal</td><td></td><td>Deprecated</td><td>The result or observation value is within the reference range or expected norm (as defined for the respective test procedure).
Note: Applies to numeric or non-numeric results.</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">ND<a name="v2-0078-ND"> </a></td><td>Not Detected</td><td></td><td>Deprecated</td><td>The presence of the specified component / analyte, organism or clinical sign could not be determined  within the limit of detection of the performed test or procedure.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NEG<a name="v2-0078-NEG"> </a></td><td>Negative</td><td></td><td>Deprecated</td><td>An absence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure.
Note: Negative does not necessarily imply the complete absence of the specified item.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NR<a name="v2-0078-NR"> </a></td><td>Non-reactive</td><td></td><td>Deprecated</td><td>An absence finding used to indicate that the specified component / analyte did not react measurably with the reagent.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NS<a name="v2-0078-NS"> </a></td><td>Non-susceptible</td><td></td><td>Deprecated</td><td>A category used for isolates for which only a susceptible interpretive criterion has been designated because of the absence or rare occurrence of resistant strains. Isolates that have MICs above or zone diameters below the value indicated for the susceptible breakpoint should be reported as non-susceptible.

Synonym: decreased susceptibility

Note 1: An isolate that is interpreted as non-susceptible does not necessarily mean that the isolate has a resistance mechanism. It is possible that isolates with MICs above the susceptible breakpoint that lack resistance mechanisms may be encountered within the wild-type distribution subsequent to the time the susceptible-only breakpoint is set.

Note 2: For strains yielding results in the “nonsusceptible” category, organism identification and antimicrobial susceptibility test results should be confirmed.</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">null<a name="v2-0078-null"> </a></td><td>No range defined, or normal ranges don't apply</td><td></td><td>Deprecated</td><td>Deprecated</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">OBX<a name="v2-0078-OBX"> </a></td><td>Interpretation qualifiers in separate OBX segments</td><td></td><td>Deprecated</td><td>Deprecated</td><td>added v2.8, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">POS<a name="v2-0078-POS"> </a></td><td>Positive</td><td></td><td>Deprecated</td><td>A presence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">QCF<a name="v2-0078-QCF"> </a></td><td>Quality Control Failure</td><td></td><td>Deprecated</td><td>Deprecated</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">R<a name="v2-0078-R"> </a></td><td>Resistant</td><td></td><td>Deprecated</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure.
Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm)
Projects: ISO 20776-1, ISO 20776-2

Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.

Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">RR<a name="v2-0078-RR"> </a></td><td>Reactive</td><td></td><td>Deprecated</td><td>A presence finding used to indicate that the specified component / analyte reacted with the reagent above the reliably measurable limit of the performed test.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">S<a name="v2-0078-S"> </a></td><td>Susceptible</td><td></td><td>Deprecated</td><td>Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success.
Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) 
Projects: ISO 20776-1, ISO 20776-2

Synonym (earlier term): Sensitive

Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.

Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SDD<a name="v2-0078-SDD"> </a></td><td>Susceptible-dose dependent</td><td></td><td>Deprecated</td><td>A category that includes isolates with antimicrobial agent minimum inhibitory concentrations (MICs) that approach usually attainable blood and tissue levels and for which response rates may be lower than for susceptible isolates.
Reference: CLSI document M44-A2 2009 “Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline – second edition” – page 2.</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SYN-R<a name="v2-0078-SYN-R"> </a></td><td>Synergy - resistant</td><td></td><td>Deprecated</td><td>A category for isolates where the bacteria (e.g. enterococci) are not susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will not be effective. 

Usage Note: Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside.

Open Issue: The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found.</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SYN-S<a name="v2-0078-SYN-S"> </a></td><td>Synergy - susceptible</td><td></td><td>Deprecated</td><td>A category for isolates where the bacteria (e.g. enterococci) are susceptible in vitro to a combination therapy (e.g., high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will be effective. 

Usage Note: Since the use of penicillin or ampicillin alone often results in treatment failure of serious enterococcal or other bacterial infections, combination therapy is usually indicated to enhance bactericidal activity. The synergy between a cell wall active agent (such as penicillin, ampicillin, or vancomycin) and an aminoglycoside (such as gentamicin, kanamycin or streptomycin) is best predicted by screening for high-level bacterial resistance to the aminoglycoside.

Open Issue: The print name of the code is very general and the description is very specific to a pair of classes of agents, which may lead to confusion of these concepts in the future should other synergies be found.</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">TOX<a name="v2-0078-TOX"> </a></td><td>Cytotoxic substance present</td><td></td><td>Deprecated</td><td>Deprecated</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">U<a name="v2-0078-U"> </a></td><td>Significant change up</td><td></td><td>Deprecated</td><td>The current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure).</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">VS<a name="v2-0078-VS"> </a></td><td>Very susceptible. Indicates for microbiology susceptibilities only.</td><td></td><td>Deprecated</td><td>Deprecated - CLSI now only supports S, I &amp; R. This information can be found in CLSI document M100-S22;  Vol. 32 No.3;  CLSI Performance
Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement.  Jan 2012.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">W<a name="v2-0078-W"> </a></td><td>Worse</td><td></td><td>Deprecated</td><td>The current result or observation value has degraded compared to the previous result or observation value (the change is significant as defined in the respective test procedure).
Note: This can be applied to quantitative or qualitative observations.</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">WR<a name="v2-0078-WR"> </a></td><td>Weakly reactive</td><td></td><td>Deprecated</td><td>A weighted presence finding used to indicate that the specified component / analyte reacted with the reagent, but below the reliably measurable limit of the performed test.</td><td>added v2.7, removed after v2.8.2</td></tr></table></div></div>
<div id="tabs-de">
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Properties</b></p><table class="grid"><tr><td><b>Code</b></td><td><b>URL</b></td><td><b>Description</b></td><td><b>Type</b></td></tr><tr><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>A property that indicates the status of the concept. One of active, experimental, deprecated, retired</td><td>code</td></tr><tr><td>deprecationDate</td><td>http://hl7.org/fhir/concept-properties#deprecationDate</td><td>The date at which a concept was deprecated. Concepts that are deprecated but not inactive can still be used, but their use is discouraged</td><td>dateTime</td></tr></table><p>This code system http://terminology.hl7.org/CodeSystem/v2-0078 defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>Deprecated</b></td><td><b>Comments</b></td><td><b>Version</b></td></tr><tr><td style="white-space:nowrap">&lt;<a name="v2-0078-.60"> </a></td><td>Unter Meßbereich (Extremwertverletzung)</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">&gt;<a name="v2-0078-.62"> </a></td><td>Über Meßbereich (Extremwertverletzung)</td><td></td><td>Deprecated</td><td></td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">A<a name="v2-0078-A"> </a></td><td>anormal</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">AA<a name="v2-0078-AA"> </a></td><td>Pathologisch (nicht numerisch)</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">AC<a name="v2-0078-AC"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">B<a name="v2-0078-B"> </a></td><td>besser</td><td></td><td>Deprecated</td><td></td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">D<a name="v2-0078-D"> </a></td><td>Deutlicher Trend nach unten</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">DET<a name="v2-0078-DET"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">H<a name="v2-0078-H"> </a></td><td>Oberhalb oberer Grenze Referenzbereich</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HH<a name="v2-0078-HH"> </a></td><td>Oberhalb oberer pathologischer Grenze</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HM<a name="v2-0078-HM"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.8, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HU<a name="v2-0078-HU"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">I<a name="v2-0078-I"> </a></td><td>Intermediär</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">IE<a name="v2-0078-IE"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">IND<a name="v2-0078-IND"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">L<a name="v2-0078-L"> </a></td><td>Unterhalb unterer Grenze Referenzbereich</td><td></td><td>Deprecated</td><td></td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">LL<a name="v2-0078-LL"> </a></td><td>Unterhalb unterer pathologischer Grenze</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">LU<a name="v2-0078-LU"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">MS<a name="v2-0078-MS"> </a></td><td>mäßig empfindlich</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">N<a name="v2-0078-N"> </a></td><td>Normal (nicht numerisch)</td><td></td><td>Deprecated</td><td></td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">ND<a name="v2-0078-ND"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NEG<a name="v2-0078-NEG"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NR<a name="v2-0078-NR"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NS<a name="v2-0078-NS"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">null<a name="v2-0078-null"> </a></td><td>Kein Referenzbereich / Referenzbereich nicht anwendbar</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">OBX<a name="v2-0078-OBX"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.8, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">POS<a name="v2-0078-POS"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">QCF<a name="v2-0078-QCF"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">R<a name="v2-0078-R"> </a></td><td>Resistent</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">RR<a name="v2-0078-RR"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">S<a name="v2-0078-S"> </a></td><td>Empfindlich</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SDD<a name="v2-0078-SDD"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SYN-R<a name="v2-0078-SYN-R"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SYN-S<a name="v2-0078-SYN-S"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">TOX<a name="v2-0078-TOX"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">U<a name="v2-0078-U"> </a></td><td>Deutlicher Trend nach oben</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">VS<a name="v2-0078-VS"> </a></td><td>Sehr empfindlich</td><td></td><td>Deprecated</td><td></td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">W<a name="v2-0078-W"> </a></td><td>Verschlechterung</td><td></td><td>Deprecated</td><td></td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">WR<a name="v2-0078-WR"> </a></td><td></td><td></td><td>Deprecated</td><td></td><td>added v2.7, removed after v2.8.2</td></tr></table></div></div>
<div id="tabs-nl">
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Eigenschappen</b></p><table class="grid"><tr><td><b>Code</b></td><td><b>URL</b></td><td><b>Omschrijving</b></td><td><b>Type</b></td></tr><tr><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>A property that indicates the status of the concept. One of active, experimental, deprecated, retired</td><td>code</td></tr><tr><td>deprecationDate</td><td>http://hl7.org/fhir/concept-properties#deprecationDate</td><td>The date at which a concept was deprecated. Concepts that are deprecated but not inactive can still be used, but their use is discouraged</td><td>dateTime</td></tr></table><p>Dit code systeem http://terminology.hl7.org/CodeSystem/v2-0078 definieert de volgende codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>Verouderd</b></td><td><b>Commentaar</b></td><td><b>Versie</b></td></tr><tr><td style="white-space:nowrap">&lt;<a name="v2-0078-.60"> </a></td><td>Onder absolute ondergrens instrumentschaal</td><td></td><td>Verouderd</td><td>Het resultaat is onder de minimum detecteerbare grens (de testprocedure of apparaat is de beperkende factor). Synoniemen: Onder analytische grens, off-scale low</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">&gt;<a name="v2-0078-.62"> </a></td><td>Boven absolute bovengrens instrumentschaal</td><td></td><td>Verouderd</td><td>Het resultaat is boven de maximum detecteerbare grens (de testprocedure of apparaat is de beperkende factor). Synoniemen: Boven analytische grens, off-scale high</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">A<a name="v2-0078-A"> </a></td><td>Abnormaal</td><td></td><td>Verouderd</td><td>Het resultaat of observatiewaarde is buiten de referentiewaarden of afwijkend van de verwachte norm (zoals gedefinieerd voor de betreffende testprocedure. NB: Meest van toepassing op niet-numerieke resultaten.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">AA<a name="v2-0078-AA"> </a></td><td>Kritiek abnormaal</td><td></td><td>Verouderd</td><td>Het resultaat of observatiewaarde is buiten de referentiewaarden of afwijkend van de verwachte norm waarvoor onmiddellijke actie ondernomen zou moeten worden uit het oogpunt van patiëntveiligheid (zoals gedefinieerd voor de betreffende testprocedure. NB: Meest van toepassing op niet-numerieke resultaten.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">AC<a name="v2-0078-AC"> </a></td><td>Anti-complementaire stoffen aanwezig</td><td></td><td>Verouderd</td><td>Vervallen</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">B<a name="v2-0078-B"> </a></td><td>Beter</td><td></td><td>Verouderd</td><td>Het huidige resultaat of observatiewaarde is verbeterd ten opzichte van vorige resultaat of observatiewaarde (de wijziging is significant zoals gedefinieerd in de betreffende testprocedure). NB: van toepassing op kwantitatieve of kwalitatieve observaties</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">D<a name="v2-0078-D"> </a></td><td>Significante wijzging omlaag</td><td></td><td>Verouderd</td><td>Het huidige resultaat is verlaagd ten opzichte van het vorige resultaat voor een kwantitatieve observatie (de wijziging is significant zoals gedefinieerd voor de betreffende testprocedure).</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">DET<a name="v2-0078-DET"> </a></td><td>Gedetecteerd</td><td></td><td>Verouderd</td><td>De meting van het gespecificeerde component / analyte, organisme of klinische teken boven de grenswaarde voor detectie van de uitgevoerde test of procedure.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">H<a name="v2-0078-H"> </a></td><td>Hoog</td><td></td><td>Verouderd</td><td>Het resultaat voor een kwalitatieve observatie is boven de bovengrens van de referentiewaarden (zoals gedefinieerd voor de betreffende testprocedure). Synoniem: Boven bovenste normaalgrens</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HH<a name="v2-0078-HH"> </a></td><td>Kritiek hoog</td><td></td><td>Verouderd</td><td>De resultaten voor een kwantitatieve observatie is boven een referentieniveau waarop onmiddellijke actie overwogen moet worden uit het oogpunt van patiëntveiligheid (zoals gedefinieerd voor betreffende testprocedure. Synoniem: Boven hoogste kritieke grens</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HM<a name="v2-0078-HM"> </a></td><td>Vastgehouden voor medische review</td><td></td><td>Verouderd</td><td>Vervallen</td><td>added v2.8, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">HU<a name="v2-0078-HU"> </a></td><td>Zeer hoog</td><td></td><td>Verouderd</td><td>Significant hoog: Een testresultaat die significant hoger is dan de referentie (normaal) of therapeutisch interval, maar nog niet op de kritiek hoger waarde zit en mogelijke speciale aandacht nodig heeft, zoals gedefinieerd door het laboratorium of de arts. NB: T</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">I<a name="v2-0078-I"> </a></td><td>Gemiddeld</td><td></td><td>Verouderd</td><td>Bacteriële stam geblokkeerd door in vitro concentratie van een anti-bacteriële agens die is gekoppeld aan een onzekere kans op therapeutisch effect. Referentie: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Ter</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">IE<a name="v2-0078-IE"> </a></td><td>Onvoldoende bewijs</td><td></td><td>Verouderd</td><td>Er is onvoldoende bewijs dat de betreffende soort een goed doel is voor therapie met de medicatie. Een categorische interpretatie is niet mogelijk. Referentie: EUCA. NB: Een MIC met "IE" en/of een opmerking wordt mogelijk gerapporteerd (zonder bijbehorende S,</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">IND<a name="v2-0078-IND"> </a></td><td>Onbepaald</td><td></td><td>Verouderd</td><td>Het gespecificeerde component / analyte, organisme of klinische teken kon niet positief / negatief of gedetecteerd / niet-gedetecteerd door de uitgevoerde test of procedure</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">L<a name="v2-0078-L"> </a></td><td>Laag</td><td></td><td>Verouderd</td><td>Het resultaat voor een kwalitatieve observatie is onder de ondergrens van de referentiewaarden (zoals gedefinieerd voor de betreffende testprocedure). Synoniem: Onder onderste normaalgrens</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">LL<a name="v2-0078-LL"> </a></td><td>Kritiek laag</td><td></td><td>Verouderd</td><td>De resultaten voor een kwantitatieve observatie is onder een referentieniveau waarop onmiddellijke actie overwogen moet worden uit het oogpunt van patiëntveiligheid (zoals gedefinieerd voor betreffende testprocedure. Synoniem: Onder laagste kritieke grens</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">LU<a name="v2-0078-LU"> </a></td><td>Zeer laag</td><td></td><td>Verouderd</td><td>Significant laag: Een testresultaat die significant lager is dan de referentie (normaal) of therapeutisch interval, maar nog niet op de kritiek lage waarde zit en mogelijke speciale aandacht nodig heeft, zoals gedefinieerd door het laboratorium of de arts. NB: T</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">MS<a name="v2-0078-MS"> </a></td><td>Gemiddeld gevoelig. Alleen voor microbiologische gevoeligheid.</td><td></td><td>Verouderd</td><td>Vervallen - CLSI ondersteunt nu alleen nog S, I &amp; R. Deze informatie vindt u in CLSI document M100-S22;  Vol. 32 No.3;  CLSI Performance
Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement.  Jan 2012.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">N<a name="v2-0078-N"> </a></td><td>Normaal</td><td></td><td>Verouderd</td><td>Het resultaat of observatiewaarde is binnen de referentiewaarden of verwachte norm (zoals gedefinieerd voor de betreffende testprocedure. NB: Van toepassing op numerieke of niet-numerieke resultaten.</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">ND<a name="v2-0078-ND"> </a></td><td>Niet-gedetecteerd</td><td></td><td>Verouderd</td><td>De meting van het gespecificeerde component / analyte, organisme of klinische teken kon niet worden gedetecteerd binnen de grenswaarde voor detectie van de uitgevoerde test of procedure.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NEG<a name="v2-0078-NEG"> </a></td><td>Negatief</td><td></td><td>Verouderd</td><td>Een afwezigheidsbevinding voor het gespecificeerde component / analyte, organisme of klinische teken gebaseerd op de geldende grenswaarde van de uitgevoerde test of procedure.
NB: Negatief betekent niet noodzakelijk de volledige afwezigheid van het het gespecificeerde item.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NR<a name="v2-0078-NR"> </a></td><td>Niet-reactief</td><td></td><td>Verouderd</td><td>Een afwezigheidsbevinding om aan te geven dat het gespecificeerde component / analyte niet meetbaar reageerde met het reagens.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">NS<a name="v2-0078-NS"> </a></td><td>Niet-gevoelig</td><td></td><td>Verouderd</td><td>Een categorie voor isolaten waarvoor alleen een gevoelig interpretabel criterium is ontworpen vanwege de afwezigheid of zeldzaam voorkomen van resistente stammen. Isolaten met MIC's boven of zonediameters onder de waarde aangewezen voor de gevoeli</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">null<a name="v2-0078-null"> </a></td><td>Geen referentiewaarden gedefinieerd of normale waarden niet van toepassing</td><td></td><td>Verouderd</td><td>Vervallen</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">OBX<a name="v2-0078-OBX"> </a></td><td>Interpretatie qualifiers in afzonderlijke OBX-segmenten</td><td></td><td>Verouderd</td><td>Vervallen</td><td>added v2.8, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">POS<a name="v2-0078-POS"> </a></td><td>Positief</td><td></td><td>Verouderd</td><td>Een aanwezigheidsbevinding voor het gespecificeerde component / analyte, organisme of klinische teken gebaseerd op de geldende grenswaarde van de uitgevoerde test of procedure.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">QCF<a name="v2-0078-QCF"> </a></td><td>Kwaliteitscontrole fout</td><td></td><td>Verouderd</td><td>Vervallen</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">R<a name="v2-0078-R"> </a></td><td>Resistent</td><td></td><td>Verouderd</td><td>Bacteriële stam geblokkeerd door in vitro concentratie van een anti-bacteriële agens die is gekoppeld aan een hoge kans op therapeutisch falen. Referentie: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmoniz</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">RR<a name="v2-0078-RR"> </a></td><td>Reactief</td><td></td><td>Verouderd</td><td>Een aanwezigheidsbevinding om aan te geven dat het gespecificeerde component / analyte reageerde met het reagens, boven de betrouwbaar meetbare grens van de uitgevoerde test.</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">S<a name="v2-0078-S"> </a></td><td>Gevoelig</td><td></td><td>Verouderd</td><td>Bacteriële stam geblokkeerd door in vitro concentratie van een anti-bacteriële agens die is gekoppeld aan een hoge kans op therapeutisch succes. Referentie: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmoniz</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SDD<a name="v2-0078-SDD"> </a></td><td>Gevoelig dosis-afhankelijk</td><td></td><td>Verouderd</td><td>Een categorie inclusief isolaten met anti-microben agens minimum blokkerende concentraties (MIC's) die in de buurt van normaal bereikbare bloed en weefsel-niveau's komen en waarvoor antwoordratio's mogelijk lager zijn dan voor gevoelige isolaten. Referentie: CLSI document</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SYN-R<a name="v2-0078-SYN-R"> </a></td><td>Synergie - resistent</td><td></td><td>Verouderd</td><td>Een categorie voor isolaten waarbij de bacteriën (bijv. enterococcen) in vitro niet gevoelig zijn voor een combinatietherapie (bijv. een hoog-niveau aminoglycoside en celwand actieve agens). Dit is een goede indicatie dat combinatietherapie niet effectief zal zijn. Gebr</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">SYN-S<a name="v2-0078-SYN-S"> </a></td><td>Synergie - gevoelig</td><td></td><td>Verouderd</td><td>Een categorie voor isolaten waarbij de bacteriën (bijv. enterococcen) in vitro gevoelig zijn voor een combinatietherapie (bijv. een hoog-niveau aminoglycoside en celwand actieve agens). Dit is een goede indicatie dat combinatietherapie effectief zal zijn. Gebr</td><td>added v2.8.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">TOX<a name="v2-0078-TOX"> </a></td><td>Cytotoxische stoffen aanwezig</td><td></td><td>Verouderd</td><td>Vervallen</td><td>added v2.7, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">U<a name="v2-0078-U"> </a></td><td>Significante wijzging omhoog</td><td></td><td>Verouderd</td><td>Het huidige resultaat is verhoogd ten opzichte van het vorige resultaat voor een kwantitatieve observatie (de wijziging is significant zoals gedefinieerd voor de betreffende testprocedure).</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">VS<a name="v2-0078-VS"> </a></td><td>Zeer gevoelig. Alleen voor microbiologische gevoeligheid.</td><td></td><td>Verouderd</td><td>Vervallen - CLSI ondersteunt nu alleen nog S, I &amp; R. Deze informatie vindt u in CLSI document M100-S22;  Vol. 32 No.3;  CLSI Performance
Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement.  Jan 2012.</td><td>from v2.1, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">W<a name="v2-0078-W"> </a></td><td>Slechter</td><td></td><td>Verouderd</td><td>Het huidige resultaat of observatiewaarde is verslechterd ten opzichte van vorige resultaat of observatiewaarde (de wijziging is significant zoals gedefinieerd in de betreffende testprocedure). NB: van toepassing op kwantitatieve of kwalitatieve observaties</td><td>added v2.2, removed after v2.8.2</td></tr><tr><td style="white-space:nowrap">WR<a name="v2-0078-WR"> </a></td><td>Zwak reactief</td><td></td><td>Verouderd</td><td>Een gewogen aanwezigheidsbevinding om aan te geven dat het gespecificeerde component / analyte reageerde met het reagens, maar onder de betrouwbaar meetbare grens van de uitgevoerde test.</td><td>added v2.7, removed after v2.8.2</td></tr></table></div></div>
</div>


<p>A current expansion is provided for this table because it is not simply 'all codes in the table', or because some codes have been deprecated</p>
<p>&nbsp;</p>
<a name="expansion"> </a>
<h2 class="self-link-parent"><span class="sectioncount">4.3.15.78.2</span> Expansion <a href="index.html#expansion" title="link to here" class="self-link"><svg viewBox="0 0 1792 1792" width="20" class="self-link" height="20"><path d="M1520 1216q0-40-28-68l-208-208q-28-28-68-28-42 0-72 32 3 3 19 18.5t21.5 21.5 15 19 13 25.5 3.5 27.5q0 40-28 68t-68 28q-15 0-27.5-3.5t-25.5-13-19-15-21.5-21.5-18.5-19q-33 31-33 73 0 40 28 68l206 207q27 27 68 27 40 0 68-26l147-146q28-28 28-67zm-703-705q0-40-28-68l-206-207q-28-28-68-28-39 0-68 27l-147 146q-28 28-28 67 0 40 28 68l208 208q27 27 68 27 42 0 72-31-3-3-19-18.5t-21.5-21.5-15-19-13-25.5-3.5-27.5q0-40 28-68t68-28q15 0 27.5 3.5t25.5 13 19 15 21.5 21.5 18.5 19q33-31 33-73zm895 705q0 120-85 203l-147 146q-83 83-203 83-121 0-204-85l-206-207q-83-83-83-203 0-123 88-209l-88-88q-86 88-208 88-120 0-204-84l-208-208q-84-84-84-204t85-203l147-146q83-83 203-83 121 0 204 85l206 207q83 83 83 203 0 123-88 209l88 88q86-88 208-88 120 0 204 84l208 208q84 84 84 204z" fill="navy"></path></svg></a></h2>
<p>This expansion generated 21 Jan 2021</p>
<hr/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This value set contains 0 concepts</p><p style="border: black 1px dotted; background-color: #EEEEEE; padding: 8px">Expansion based on http://terminology.hl7.org/CodeSystem/v2-0078 version 2.9</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>System</b></td><td><b>Display</b></td></tr></table></div>

</div>


				</div>  <!-- /inner-wrapper -->
            </div>  <!-- /row -->
        </div>  <!-- /container -->
        
    </div>  <!-- /segment-content -->


	<div id="segment-footer" class="segment">  <!-- segment-footer -->
		<div class="container">  <!-- container -->
			<div class="inner-wrapper">
				<p>
        &reg;&copy; HL7.org 2011+. FHIR Release 4 (Technical Correction #1) (v4.0.1) generated on Thu, Jan 21, 2021 15:39+0000. <a style="color: #ffffff" href="../../qa.html">QA Page</a>
        <br/>
        <span style="color: #FFFF77">
        Links: <a style="color: #b8dcf9" href="http://hl7.org/fhir/search.cfm">Search <img src="../../external.png" style="text-align: baseline"/></a> | 
               <a style="color: #b8dcf9" href="../../history.html">Version History</a> | 
               <a style="color: #b8dcf9" href="../../toc.html">Table of Contents</a> | 
               <a style="color: #b8dcf9" href="../../credits.html">Credits</a> | 
               <a style="color: #b8dcf9" href="http://services.w3.org/htmldiff?doc1=http%3A%2F%2Fhl7.org%2Ffhir%2FSTU3%2Fv2%2F0078%2Findex.html&amp;doc2=http%3A%2F%2Fbuild.fhir.org%2F%2Fv2%2F0078%2Findex.html">Compare to R3 <img src="../../external.png" style="text-align: baseline"/></a> |                
               <a rel="license" style="color: #b8dcf9" href="../../license.html"><img src="../../cc0.png" alt="CC0" style="border-style: none;"/></a> | 
               <a style="color: #b8dcf9" href="http://hl7.org/fhir-issues" target="_blank">Propose a change <img src="../../external.png" style="text-align: baseline"/></a>   
        </span>
        </p>
			</div>  <!-- /inner-wrapper -->
		</div>  <!-- /container -->
	</div>  <!-- /segment-footer -->
  <!-- disqus thread -->
  <!-- disqus -->
  <!-- end disqus -->        
	
	<div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
		<div class="container">  <!-- container -->
		</div>  <!-- /container -->
	</div>  <!-- /segment-post-footer -->
    
      <!-- JS and analytics only. -->
      <!-- Bootstrap core JavaScript
================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
<script src="../.././assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
<script src="../.././dist/js/bootstrap.min.js"> </script>
<script src="../.././assets/js/respond.min.js"> </script>

<script src="../.././assets/js/fhir.js"> </script>

  <!-- Analytics Below
================================================== -->

    
    
<script src="external/jquery/jquery.js"> </script>
<script src="../../jquery-ui.min.js"> </script>
<script>
try {
  var currentTabIndex = sessionStorage.getItem('fhir-cslang-tab-index');
}
catch(exception){
}

if (!currentTabIndex)
  currentTabIndex = '0';

$( '#tabs' ).tabs({
         active: currentTabIndex,
         activate: function( event, ui ) {
             var active = $('.selector').tabs('option', 'active');
             currentTabIndex = ui.newTab.index();
             document.activeElement.blur();
             try {
               sessionStorage.setItem('fhir-cslang-tab-index', currentTabIndex);
             }
             catch(exception){
             }
         }
     });
</script>

</body>
</html>